eCite Digital Repository

Phytomedicines targeting cancer stem cells: Therapeutic opportunities and prospects for pharmaceutical development

Citation

Gupta, PK and Saraff, M and Gahtori, R and Negi, N and Tripathi, SK and Kumar, J and Kumar, S and Aldhayan, SH and Dhanasekaran, S and Abomughaid, MM and Dua, K and Gundamaraju, R and Ojha, S and Ruokolainen, J and Jha, NK and Kesari, KK, Phytomedicines targeting cancer stem cells: Therapeutic opportunities and prospects for pharmaceutical development, Pharmaceuticals, 14, (7) pp. 1-25. ISSN 1424-8247 (2021) [Refereed Article]


Preview
PDF
2Mb
  

Copyright Statement

Copyright 2021 the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).

DOI: doi:10.3390/ph14070676

Abstract

The presence of small subpopulations of cells within tumor cells are known as cancer stem cells (CSCs). These cells have been the reason for metastasis, resistance with chemotherapy or radiotherapy, and tumor relapse in several types of cancers. CSCs underwent to epithelial-mesenchymal transition (EMT) and resulted in the development of aggressive tumors. CSCs have potential to modulate numerous signaling pathways including Wnt, Hh, and Notch, therefore increasing the stem-like characteristics of cancer cells. The raised expression of drug efflux pump and suppression of apoptosis has shown increased resistance with anti-cancer drugs. Among many agents which were shown to modulate these, the plant-derived bioactive agents appear to modulate these key regulators and were shown to remove CSCs. This review aims to comprehensively scrutinize the preclinical and clinical studies demonstrating the effects of phytocompounds on CSCs isolated from various tumors. Based on the available convincing literature from preclinical studies, with some clinical data, it is apparent that selective targeting of CSCs with plants, plant preparations, and plant-derived bioactive compounds, termed phytochemicals, may be a promising strategy for the treatment of relapsed cancers.

Item Details

Item Type:Refereed Article
Keywords:phytomedicines, phytochemicals, stem cells, signaling pathway, epithelial–mesenchymal transition, preclinical, clinical research
Research Division:Biomedical and Clinical Sciences
Research Group:Oncology and carcinogenesis
Research Field:Cancer therapy (excl. chemotherapy and radiation therapy)
Objective Division:Health
Objective Group:Clinical health
Objective Field:Treatment of human diseases and conditions
UTAS Author:Gundamaraju, R (Mr Rohit Gundamaraju)
ID Code:146429
Year Published:2021
Deposited By:Health Sciences
Deposited On:2021-09-07
Last Modified:2021-10-25
Downloads:7 View Download Statistics

Repository Staff Only: item control page